CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market buy Chief Medical Officer bought 1,150 shares at an average $2.19 ($2,520)
- 4 Open-market buy CEO and Director bought 10,000 shares at an average $1.89 ($18,945)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy CEO and Director bought 10,308 shares at $2.80 ($28,862)
- EFFECT Other Notice of Effectiveness
- RW Other RW
- 4 Open-market buy Chief Business Officer bought 150 shares at $2.62 ($393)
Page 12 of 18 · 343 filings